AKT1 and neoplasm: The effects are supported by the compound's ability to regulate a variety of oncogenic and tumor‐suppressive signaling pathways, particularly PI3K/Akt, STAT3, NF‐kB, MAPK, AMPK, and Wnt/beta‐catenin.